A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Finerenone may lower risks for kidney and cardiovascular events for adults with chronic kidney disease and type 2 diabetes, ...

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

People often ask whether Ozempic helps them lose weight. Clinical trials have shown reductions in body weight among adults ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

Both Wegovy and Ozempic are semaglutide – a drug that first entered the US market in 2017 as a diabetes medication. It was ...

The 61-year-old man received a new kidney from a deceased donor after being diagnosed with “nephrosclerosis-related end-stage ...

Question: I am a woman with a BMI of 31 and have recently been put on statins for high cholesterol. I have also been told ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs ...